These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In Vitro Effect of Epigallocatechin Gallate on Heme Synthesis Pathway and Protoporphyrin IX Production. León D; Reyes ME; Weber H; Gutiérrez Á; Tapia C; Silva R; Viscarra T; Buchegger K; Ili C; Brebi P Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201369 [TBL] [Abstract][Full Text] [Related]
3. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species. Dogra Y; Ferguson DCJ; Dodd NJF; Smerdon GR; Curnow A; Winyard PG Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766 [TBL] [Abstract][Full Text] [Related]
4. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy. Sebastian A; Allan E; Allan D; Colthurst J; Bayat A J Dermatol Sci; 2011 Dec; 64(3):174-84. PubMed ID: 22015050 [TBL] [Abstract][Full Text] [Related]
5. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy. Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103 [TBL] [Abstract][Full Text] [Related]
6. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study. Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310 [TBL] [Abstract][Full Text] [Related]
7. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4. Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138 [TBL] [Abstract][Full Text] [Related]
8. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Anand S; Honari G; Hasan T; Elson P; Maytin EV Clin Cancer Res; 2009 May; 15(10):3333-43. PubMed ID: 19447864 [TBL] [Abstract][Full Text] [Related]
9. Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells. Cicarma E; Tuorkey M; Juzeniene A; Ma LW; Moan J Br J Dermatol; 2009 Aug; 161(2):413-8. PubMed ID: 19438460 [TBL] [Abstract][Full Text] [Related]
10. Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study. Bay C; Togsverd-Bo K; Lerche CM; Haedersdal M J Photochem Photobiol B; 2016 Jan; 154():34-9. PubMed ID: 26678673 [TBL] [Abstract][Full Text] [Related]
12. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Blake E; Allen J; Thorn C; Shore A; Curnow A Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533 [TBL] [Abstract][Full Text] [Related]
13. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy. Anayo L; Magnussen A; Perry A; Wood M; Curnow A Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy. Lucena SR; Zamarrón A; Carrasco E; Marigil MA; Mascaraque M; Fernández-Guarino M; Gilaberte Y; González S; Juarranz A Sci Rep; 2019 Mar; 9(1):4835. PubMed ID: 30886381 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice. Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459 [TBL] [Abstract][Full Text] [Related]
18. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Tyrrell JS; Campbell SM; Curnow A Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386 [TBL] [Abstract][Full Text] [Related]
19. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Anand S; Rollakanti KR; Horst RL; Hasan T; Maytin EV Photochem Photobiol; 2014; 90(5):1126-35. PubMed ID: 24807677 [TBL] [Abstract][Full Text] [Related]
20. Fluorouracil Enhances Photodynamic Therapy of Squamous Cell Carcinoma via a p53-Independent Mechanism that Increases Protoporphyrin IX levels and Tumor Cell Death. Anand S; Rollakanti KR; Brankov N; Brash DE; Hasan T; Maytin EV Mol Cancer Ther; 2017 Jun; 16(6):1092-1101. PubMed ID: 28336806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]